Skip to content

Assessing the Potential of C-Reactive Protein Testing to Reduce Antibiotic Dispensation for Respiratory Tract Infections by Community Pharmacists in Nigeria: A Cluster Randomised Controlled Trial

Assessing the Potential of C-Reactive Protein Testing to Reduce Antibiotic Dispensation for Respiratory Tract Infections by Community Pharmacists in Nigeria: A Cluster Randomised Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202111611256940
Enrollment
20
Registered
2021-11-30
Start date
2022-01-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotic use for respiratory tract infections

Interventions

Usual practice
CRP test kits provision and training

Sponsors

Augustine Onwunduba
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: To be included, a community pharmacy must be registered with the Pharmacists Council of Nigeria (PCN) and have at least one pharmacist, who is registered with PCN, on duty always.

Exclusion criteria

Exclusion criteria: Prospective community pharmacies will be excluded if their managements do not consent to their participating or if their community pharmacists already use a diagnostic technique to inform antibiotic dispensation to patients with RTI symptoms.

Design outcomes

Primary

MeasureTime frame
This is the rate at which community pharmacists dispense antibiotics to patients with symptoms of RTI.

Secondary

MeasureTime frame
This is the rate at which community pharmacists incorporate the results of objective medical tests when making decisions regarding antibiotic dispensation to patients with symptoms of RTI.

Countries

Nigeria

Contacts

Public ContactAugustine Onwunduba

Lecturer

ae.onwunduba@unizik.edu.ng+2347061175220

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026